Facilitate medical research that advances human health

SAFEGLP

SAFE Pharmaceutical Technology Company, Limited.

NEWS

MORE+
SAFE's participation in " The repeated administration of rhIL-12 for 14 weeks in rhesusmonkeys: A toxicity assessment" is officially in press

10-08

2023
SAFE's participation in "Targeting and Cytotoxicity of Chimeric Antigen Receptor T Cells Transplanted with PD1 Extramembrane Structural Domains" is officially in press

10-07

2023
SAFE Preclinical Safety Evaluation Center Received 9 GLP Certifications from National Medical Products Administration

11-20

2019
ROHTO Pharmaceutical Co.,Ltd. visited Guoke SAFE Hebei Pharmaceutical Technology Co., Ltd. to discuss cooperation

08-26

2019
SAFE Pharmaceutical Laboratory passed the verification of the detection ability of macromolecular biological samples of the National Institute of Food and Drug Control

07-25

2019
SAFE Pharmaceutical Research Institute and PerkinElmer Collaborative Innovation Center of New Drug Evaluation

05-06

2019
SAFE's participation in " The repeated administration of rhIL-12 for 14 weeks in rhesusmonkeys: A toxicity assessment" is officially in press

10-08

2023
SAFE's participation in "Targeting and Cytotoxicity of Chimeric Antigen Receptor T Cells Transplanted with PD1 Extramembrane Structural Domains" is officially in press

10-07

2023
SAFE Preclinical Safety Evaluation Center Received 9 GLP Certifications from National Medical Products Administration

11-20

2019
ROHTO Pharmaceutical Co.,Ltd. visited Guoke SAFE Hebei Pharmaceutical Technology Co., Ltd. to discuss cooperation

08-26

2019
SAFE Pharmaceutical Laboratory passed the verification of the detection ability of macromolecular biological samples of the National Institute of Food and Drug Control

07-25

2019
SAFE Pharmaceutical Research Institute and PerkinElmer Collaborative Innovation Center of New Drug Evaluation

05-06

2019
MEMORABILIA

2021

2020

2019

2018

2017

2016

2021

July

200余名应届毕业生加入赛赋胡杨成长营;
完成第一个干细胞IND申报项目;
一站式项目20余个,累计项目金额超1亿元;
赛赋医药员工总数突破700人;
累计签约订单总额突破5亿元。

June

与河北医科大学达成人才战略合作。

May

固安实验室二期开工建设,建成后固安实验室面积共计20000余平。赛赋医药集团总设施面积超70000平;
赛赋医药胡杨林计划启动;
与沈阳科技学院、辽宁医药职业学院达成人才战略合作。

April

承接第一个mRNA的IND申报项目。

March

苏州赛赋合作协议签订,并开工建设30000平米GLP实验室;
完成重组抗破伤风毒素抗体药物的美国FDA IND 申报。

February

赛赋医药安评中心取得AAALAC认证。

January

四川赛赋实验室建设完成;
深圳赛赋获得CMA资质认定;
承接第一个罕见病基因治疗药物的IND申报项目。

2020

2019

2018

2017

2016

WeChat